Always consult a qualified provider from BodyLogicMD before starting any new medication or treatment regimen.
However, brand trust, IP defense, and clinical validation will remain Novo and Lillys strongest moats in premium markets such as the USA, EU, and Japan, where regulatory standards and reimbursement frameworks still favor established innovators
During menopause, when hunger signals become less reliable and insulin resistance develops, semaglutide can help restore these regulatory pathways, making it easier to eat smaller portions and feel satisfied longer
Eli Lilly and Company Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimers and Parkinsons disease models
When should I call my doctor